24 results
8-K
EX-4.1
NBRVF
Nabriva Therapeutics plc
27 Sep 21
Entry into a Material Definitive Agreement
8:57am
10-K
2020 FY
EX-4.1
NBRVF
Nabriva Therapeutics plc
Annual report
11 Mar 21
4:26pm
8-K
EX-4.1
NBRVF
Nabriva Therapeutics plc
1 Mar 21
Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:28pm
8-K
EX-4.2
NBRVF
Nabriva Therapeutics plc
1 Mar 21
Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:28pm
S-3
EX-4.3
NBRVF
Nabriva Therapeutics plc
Shelf registration
1 Sep 20
4:50pm
8-K
EX-4.1
4o3gtk8w
1 Jun 20
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6:28am
8-K
EX-4.1
e3z7ppt3
20 Dec 19
Nabriva Therapeutics Announces $20 Million Registered Direct Offering
9:07am
S-3
EX-4.4
cszysu96p
28 Jul 17
Shelf registration
12:00am
S-3
EX-4.3
caf98u0ik64
28 Jul 17
Shelf registration
12:00am
S-3
EX-4.5
6ndd76jmsgywa1lxe4
28 Jul 17
Shelf registration
12:00am
S-3
EX-4.2
3lz c0quk
28 Jul 17
Shelf registration
12:00am
20-F
EX-4.12
w3sb7qx
28 Apr 16
Annual report (foreign)
12:00am